HTG Molecular Diagnostics, Inc. Gains 117.57%
HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ) rocketted at $0.54, representing a gain of 117.6%. On Fri, Dec 09, 2022, HTGM:NASDAQ touched a New 2-Week High of $0.54. The stock appeared on our News Catalysts scanner on Thu, Nov 10, 2022 at 06:56 PM in the 'EARNINGS' category. From Fri, Nov 25, 2022, the stock recorded 20.00% Up Days and 9.09% Green Days
The stock spiked on Fri, Dec 09, 2022 at $0.75 with a volume of 41M+.
About HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ)
HTG Molecular Diagnostics Inc is a commercial stage company. It develops & markets a novel technology platform to facilitate the routine use of complex molecular profiling with its focus on clinical applications.
Top 10 Gainers:
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 1007.59%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 117.57%
- ClearOne, Inc. (CLRO:NASDAQ), 73.4%
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 53.24%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 43.41%
- Rockley Photonics Holdings Limited (RKLY:NYSE), 40.39%
- Cardiol Therapeutics Inc. (CRDL:NASDAQ), 38.3%
- PainReform Ltd. (PRFX:NASDAQ), 37.21%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 35.97%
- Acer Therapeutics Inc. (ACER:NASDAQ), 35.67%